Navigation Links
Particle Sciences Acquires Additional Space for Operations
Date:11/10/2009

BETHLEHEM, Pa., Nov. 10 /PRNewswire/ -- Particle Sciences Inc., a leading pharmaceutical CRO, has further expanded their capabilities by the acquisition of additional space bringing their total to approximately 21,000 sq ft. "Our current workload and existing pipeline simply necessitates this addition," says Dr. Mark Mitchnick, CEO. "2009 has been a record year for us and we have pretty good visibility on the next 12 months. The additional space will be used to expand our cGMP warehouse capacity. Also, we will construct a purpose-built sampling and weighing area for highly potent materials," says Mitchnick. According to Robert Lee, PhD, Particle Sciences VP of Pharmaceutical Development, "Increasingly, clients are coming to us for clinical trial material manufacturing and to work with a greater number of highly potent compounds. We are fortunate that we are able to expand into both of those needs." Particle Sciences expects the new space to be operational in Q1 2010.

Particle Sciences is an integrated provider of drug development services. Particle Sciences focuses on emulsions, gels, particulates and drug/device combination products with additional specialized capabilities in topical and mucosal drug delivery. Through a full range of formulation, analytic, and manufacturing services, Particle Sciences provides pharmaceutical companies with a complete and seamless development solution that minimizes the time and risk between discovery and the clinic. The company was founded in 1991 and is headquartered in Bethlehem, Pennsylvania. Visit http://www.particlesciences.com, email info@particlesciences.com or contact us at (610) 861-4701 for information.

    Contact:
    Maureen Cochran
    '/>"/>
SOURCE Particle Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Pitt-led researchers create nanoparticle coating to prevent freezing rain buildup
2. Particle Sciences, Inc. and Dow Corning Corporation Cooperate to Develop New Product Technology
3. New CapSure™ Cleanroom Wiper from Berkshire Corporation Captures and Retains 42 Times More Contaminant Particles
4. Engineers produce how-to guide for controlling the structure of nanoparticles
5. New discovery reveals fate of nanoparticles in human cells
6. NOVAVAX Announces Positive Results for the Second Phase II Clinical Trial of its Trivalent Seasonal Influenza Virus-like Particle (VLP) Vaccine Candidate
7. Bio-enabled, surface-mediated approach produces nanoparticle composites
8. NOVAVAX Virus-Like Particle Vaccine Protects Against 2009 Pandemic H1N1 Influenza Virus
9. Capping a two-faced particle gives duke engineers complete control
10. Nanotech particles affect brain development in mice
11. Particle Sciences and Microfluidics Collaborate to Share Formulation and Nanotechnology Expertise for Pharmaceutical Drug Product Development, Analysis and Commercialization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... 26, 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or ... company that develops and commercializes proprietary technologies and products ... operational results for the fiscal first quarter ended December ... in Canadian dollars (CAD), unless otherwise stated. ... new business from our existing customers and add to ...
(Date:2/26/2015)... The Movement for Indefinite Life Extension (MILE) ... technologies and awareness. The event is taking place from ... 21st 2015, in a live Google Hangout broadcast from ... of MILE, says, “Our lives are in our hands, ... Indefinite Life Extension is raising awareness about bio-sciences and ...
(Date:2/26/2015)... The Pittcon 2015 Exposition, which ... N. Morial Convention Center in New Orleans, Louisiana, ... 19, 2015) displaying products and services used by ... labs. The Exposition will offer the latest innovations ... analytical chemistry; drug discovery; nanotechnology; life sciences to ...
(Date:2/26/2015)... , Feb. 26, 2015  Dyadic International, ... whose patented and proprietary technologies are used to ... for the bioenergy, bio-based chemical, biopharmaceutical and industrial ... its financial results for year ending December 31, ... 2015 and will host a conference call that ...
Breaking Biology Technology:SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6Indefinite Life Extension Activists Organize Online Demonstration 2Indefinite Life Extension Activists Organize Online Demonstration 3Pittcon 2015 Announces Exposition Highlights 2Dyadic International To Announce Fourth Quarter 2014 Financial Results And Host Conference Call On Wednesday, March 11, 2015 2Dyadic International To Announce Fourth Quarter 2014 Financial Results And Host Conference Call On Wednesday, March 11, 2015 3
... Researchers at Oregon State University and other institutions have ... rods of gold that will have important applications in ... is at least 10 times more sensitive than existing ... types of materials and is easy to make in ...
... (CAS) announce the publication of strategic reports planning the ... (S&T). The first general report will be presented by ... the Chinese STM publisher Science Press and Springer during ... Frankfurt Book Fair. All reports are co-published in English ...
... SAN DIEGO, Oct. 13 SpectraScience, Inc. (OTC Bulletin ... today announced that it has engaged Bielderman BVBA, an ... process for its Barrett,s esophageal cancer application under trial ... used in the Company,s application to the Food and ...
Cached Biology Technology:New nanotech sensor developed with medical, chemistry applications 2Science and Technology Roadmaps to China 2050 2SpectraScience Engages European Contract Research Organization to Manage Clinical Trials 2SpectraScience Engages European Contract Research Organization to Manage Clinical Trials 3
(Date:2/13/2015)... 13, 2015 ACT Genomics Co., Ltd., ... to transform cancer genomic information into precision diagnosis ... has raised US$ 8 million in the its first ... Taipei, Taiwan , ACT Genomics has ... the aim to implement next generation sequencing (NGS) ...
(Date:2/11/2015)... February 11, 2015 ... "Access Control Market by Product (Cards and Readers, Biometrics, ... Defense, Government, Industrial, Healthcare, Education) and By Geography - Global ... MarketsandMarkets, the Access Control Market is expected ... at a CAGR of 10.6% between 2014 ...
(Date:2/5/2015)... RESEARCH TRIANGLE PARK, North Carolina , ... in sein 35. Jahr als spezialisiertes Logistikunternehmen ... seine Position als einzige klinische Logistikfirma (Clinical ... soll. Die Kernbotschaft der neuen Kampagne lautet ... Protokollen und Lieferungen. Foto: ...
Breaking Biology News(10 mins):ACT Genomics Raises $8 Million in its First Private Funding Round 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3
... into your garden armed with plants, consider who you place ... plant isn’t as passive as widely assumed, at least not ... get fiercely competitive when forced to share their pot with ... with their siblings. , The study appears today in ...
... Type 2 diabetes are at double the risk of having ... research from the University of Alberta. It was found that ... first five years of treatment for Type 2 diabetes and ... study, the researchers entered 12,272 subjects into a Type 2 ...
... have engineered artificial blood vessels from muscle-derived stem ... extensive remodeling and remain free of blockages when ... which is being presented at the Tissue Engineering ... Chapter meeting being held June 13 to 16 ...
Cached Biology News:Plants recognize their siblings, biologists discover 2University of Pittsburgh School of Medicine researchers develop 'off-the-shelf' vascular grafts 2
Request Info...
Prepared with distilled water. Yeast extract solution is autolyzed at 150 g/L....
Streptomycin sulfate an aminoglycoside used for bacterial selection binds to the small ribosomal subunit and interferes with protein biosynthesis.21H39N7O12)2x3H2SO4Formula weight:...
...
Biology Products: